Electronic Theses and Dissertations (PhDs)

Permanent URI for this collection

https://hdl.handle.net/10539/38002

Browse

Browsing Electronic Theses and Dissertations (PhDs) by Keyword "Cancer"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Biophysical studies of metal chelate binding by HSA: Towards an understanding of metallodrug transport
    (University of the Witwatersrand, Johannesburg, 2023) Sookai, Sheldon; Munro, Orde
    Human serum albumin (HSA) is the most abundant blood protein, transporting many exogenous compounds including clinically deployed and investigational drugs that are generally organic in nature. HSA may largely influence the pharmacokinetics and pharmacodynamics of these drugs. Therefore, studying their interactions with HSA is vital in progressing drug development. In this thesis we present work on the synthesis and characterisation of five Schiff base bis(pyrrolide-imine) ligands that were metalated with either Au(III) (Chapters 2 and 3) or Pt(II) (Chapters 4 and 5). One of the ligands H2L1 was further metalated with Ni(II) and Pd(II) (Chapter 6). In Chapters 2 and 3 focus on a patented class of anti-cancer bis(pyrrolide-imine) Au(III) Schiff base chelates. Three Au(III) chelates were synthesized in Chapter 2 and underwent National Cancer Institute (NCI)-60 cytotoxic screening. Among them, AuL1 and AuL3 underwent full-five dose testing and recorded GI50 values of 7.3 µM and 11.5 µM, and IC50 values of 15.7 µM and 30.9 µM, respectively. AuL1 was tested further and found to be an interfacial poison of topoisomerase II at 0.5–5 µM and a catalytic inhibitor at 50 µM. In Chapter 3, two chiral tetradentate cyclohexane-1,2-diamine-bridged bis(pyrrole-imine) Au(III) complexes were reported, both of which were found to be cytotoxic in the NCI-60 screen. The chiral Au(III) chelates had a different mode of action compared to AuL1. Hierarchical cluster analysis suggest that their mode of action is similar to that of taxol. All five Au(III) chelates bound to HSA with moderate affinity (104–105 M–1) and minimally perturbed the structure of the protein. This highlights the potential for the Au(III) complexes to be transported by the HSA-mediated pathway. Chapters 4 and 5 focused on the synthesis of novel and previously reported Pt(II) Schiff base chelates to spectroscopically and computationally study their interaction with HSA and elucidate if the chelates could act as theranostic agents. It was found that switching the linking bis(imine) carbon linkage altered the binding affinity of the complex. However, the Pt(II) ion ensured that all three Pt(II) chelates preferred binding to Sudlow’s site II of HSA. The data was corroborated by molecular docking simulations and ONIOM calculations. Only 2 was found to be cytotoxic when irradiated with UV light but was found to act as a photosensitizer rather than a theranostic agent. Chapter 6 investigated the influence of d8 metal ions (Ni(II), Pd(II) and Pt(II) within the same ligand scaffold (H2PrPyrr) binding to HAS, which was investigated by steady state fluorescence quenching. The affinity constants, Ka, ranged from -3.5 -103 M−1 to-1- 106 M–1 at 37 C, following the order Pd(PrPyrr) > Pt(PrPyrr) > Ni(PrPyrr) >H2PrPyrr. The Pd(II) chelate was prone to hydrolysis and had a unique binding mode which we attribute to the unusually high binding affinity. The complexes uptake is enthalpically driven, hinging mainly on London dispersion forces. In summation, twelve metal complexes were successfully synthesized, of which 11 bound to HSA with a moderate binding affinity. The Au(III) chelates preferred Sudlow’s site I, while the Pt(II) chelates preferred Sudlow’s site II. Overall, the metal complexes bound fully intact to HSA.
  • Thumbnail Image
    Item
    Synthesis, characterization and investigation of the mode of action in the anticancer activity of novel platinum complexes
    (University of the Witwatersrand, Johannesburg, 2024) Peega, Tebogo; Harmse, Leonie; Kotzé, Izak. A.
    Cancer remains a global health concern, causing approximately 10 million deaths in 2020. Lung cancer, accounting for 18% of cancer-related deaths, and colorectal cancer, contributing 9.4%, are major contributors to this alarming statistic, emphasizing the urgent need for innovative and effective treatment options. Despite the success of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin, their limitations and severe adverse effects necessitate the exploration of alternative chemotherapeutic agents. This research project focused on synthesizing and characterizing square planar platinum(II) complexes bearing variations of two bidentate coordinating ligands; disubstituted acylthiourea and diimine ligands, each possessing unique physical and chemical properties. A series of cationic [Pt(diimine)(Ln-κO,S)]Cl complexes were successfully synthesized and characterized using nuclear magnetic resonance spectroscopy, infrared spectroscopy, mass spectrometry, and elemental analysis. The anticancer activity of these complexes was evaluated against two lung cancer cell lines, A549 and H1975, and a colorectal cancer cell line, HT-29. In vitro cytotoxicity studies included the determination of IC50 values of active complexes and assessing their cell death mechanisms through multiple biochemical marker assays. These included annexin-V binding, caspase-3/7 and caspase-8 activity, mitochondrial membrane potential (MMP), reactive oxygen species (ROS) and immunofluorescence for the expression of key proteins involved in the DNA damage response and oxidative stress response, such as p21 and haemoxygenase-1 (HO-1). A proteome array was employed to investigate the effects on apoptosis-associated proteins. The results indicated that these platinum complexes were more cytotoxic than cisplatin with IC50 values ranging between 0.68 μM and 2.28 μM. Further investigation showed that the platinum complexes induced cell stress, chromatin condensation, nuclear fragmentation, increased phosphatidylserine (PS) on the outer cell membranes and activated caspase-3/7. Platinum complexes induced intrinsic apoptosis in cancer cells, as evidenced by the loss of mitochondrial membrane potential and the absence of caspase-8 activity. Elevated ROS levels, increased HO-1 expression and increased expression of p21 suggested oxidative stress and DNA damage as the trigger source for intrinsic apoptotic cell death. The active complexes downregulated pro-survival proteins (IGFs) in lung cancer cells and anti-apoptotic proteins (survivin and HSP70) and upregulated pro-apoptotic proteins (p21, TRAIL R2), across the three cancer cell lines, indicating potential dual activation of apoptotic pathways. DNA binding studies indicated groove binding and intercalation as the mode of interaction with DNA. The findings highlight the potential of these platinum complexes as promising candidates for further development as cancer therapeutics.